The OD shift in dlGN is independent from V1 feedback in adult mice but not in critical period mice.
A & B, Muscimol injection in V1 has no effect on the ODI in dLGN of adult non-deprived WT (A) and KO (B) mice (Wilcoxon signed rank; WT NO MD vs. WT NO MD with muscimol, P=0.86, n=40 units, 7 mice; KO NO MD vs. KO NO MD with muscimol, P=0.45, 45 units, 9 mice). C, D & E, Muscimol injection in V1 has no significant effect on the ODI (C), or contralateral (D) or ipsilateral (E) eye responses in dLGN of monocularly deprived WT mice (Wilcoxon signed rank; ODI, WT MD vs. WT MD with muscimol, P=0.89; contralateral, WT MD vs. WT MD with muscimol, P=0.21; ipsilateral, WT MD vs. WT MD with muscimol, P=0.10, n=22 units, 6 mice). F, G & H, During the critical period, V1 silencing has a significant influence on the ODI (F) and ipsilateral eye responses (H) in dLGN of monocularly deprived WT mice, but not on contralateral eye responses in these mice (G) (Wilcoxon signed rank; ODI, WT MD vs. WT MD with muscimol, P<0.001; contralateral, WT MD vs. WT MD with muscimol, P=0.46; ipsilateral, WT MD vs. WT MD with muscimol, P=0.003, n=41 units, 10 mice). I, J & K, Muscimol injection in V1 has no significant influence on the ODI and contralateral eye responses in KO MD mice, but significantly modulates dLGN ipsilateral eye responses (Wilcoxon signed rank; ODI, KO MD vs. KO MD with muscimol, P=0.13; contralateral, KO MD vs. KO MD with muscimol, P=0.97; ipsilateral, KO MD vs. KO MD with muscimol, P=0.004, n=34 units, 9 mice).